Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-41

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) with gemcitabine, after cytoreductive surgery, may reduce the tumor progression of pancreatic cancer through the reduction of the neoplastic volume and the subpopulation of residual pancreatic cancer stem cells, improving the survival of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Gastrointest Oncol
Main Authors: Padilla-Valverde, David, García-Santos, Esther, Sanchez, Susana, Manzanares, Carmen, Rodriguez, Marta, González, Lucia, Ambrós, Alfonso, Cano, Juana M., Serrano, Leticia, Bodoque, Raquel, Vergara, Teresa, Martin, Jesus
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2021
Teme:
Original Article on Pancreas Cancer
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100727/
https://ncbi.nlm.nih.gov/pubmed/33968428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-238
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki